Skip to content
PatientMatchFind trials

Screener

Eligibility screening

Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

Sponsored by SanofiStudy detailsClinicalTrials.gov

27 US sites in AZ, CA, CO, CT +13

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.